Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.709
-$0.0449-5.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.03% | -36.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.74% | 4.09% | |||
| Operating Income | 25.74% | -4.09% | |||
| Income Before Tax | 25.23% | -6.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.18% | -6.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.18% | -6.44% | |||
| EBIT | 25.74% | -4.09% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 33.98% | 3.77% | |||
| Normalized Basic EPS | 34.07% | 3.67% | |||
| EPS Diluted | 33.98% | 3.77% | |||
| Normalized Diluted EPS | 34.07% | 3.67% | |||
| Average Basic Shares Outstanding | 13.35% | 10.64% | |||
| Average Diluted Shares Outstanding | 13.35% | 10.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||